Lyra Therapeutics | 4:持股變動聲明-高管 Palasis Maria
Lyra Therapeutics | 4:持股變動聲明-高管 Cavalier Jason
Lyra Therapeutics | SC 13D/A:超過5%持股股東披露文件(修正)-Perceptive Advisors LLC(19.5%),Joseph Edelman(19.5%)等
Lyra Therapeutics | 4:持股變動聲明-董事 ALTMAN MICHAEL SETH
Lyra Therapeutics | 4:持股變動聲明-董事 Poukalov Konstantin
Lyra Therapeutics | 4:持股變動聲明-董事 TOBIN JAMES R
Lyra Therapeutics | 4:持股變動聲明-董事 snyderman nancy lynn MD
Lyra Therapeutics | 4:持股變動聲明-董事 Smith W Bradford
Lyra Therapeutics | 4:持股變動聲明-董事 MERRIFIELD C ANN
Lyra Therapeutics | 4:持股變動聲明-高管 Waksal Harlan
Lyra Therapeutics | 4:持股變動聲明-高管 Palasis Maria
Lyra Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Venrock Healthcare Capital Partners II, L.P.(9.999%),VHCP Co-Investment Holdings II, LLC(9.999%)等
Lyra Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Citadel Advisors LLC(7.9%),Citadel Advisors Holdings LP(7.9%)等
Lyra Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Steven A. Cohen(5.8%),Point72 Asset Management, L.P.(5.7%)等
Lyra Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Nantahala Capital Management, LLC(8.9%),Wilmot B. Harkey(8.9%)等
Lyra Therapeutics | SC 13D/A:超過5%持股股東披露文件(修正)-Perceptive Advisors LLC(24.3%),Joseph Edelman(24.3%)等
Lyra Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Pura Vida Investments, LLC(3.06%),Efrem Kamen(3.06%)
Lyra Therapeutics | SC 13G:超過5%持股股東披露文件-Vestal Point Capital, LP(5.7%),Ryan Wilder(5.7%)
Lyra Therapeutics | 4:持股變動聲明-高管 Nieman Richard
Lyra Therapeutics | 4:持股變動聲明-高管 Bishop John E
暫無數據
暫無數據